Flagship Pioneering Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
59

- Investments
-
337
- Portfolio
-
36
- Exits
-
155

Flagship Pioneering General Information
Description
Founded in 2000, Flagship Pioneering is a venture capital investment firm that prefers to invest in the health technologies and life science sectors. The firm is based in Cambridge, Massachusetts.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 55 Cambridge Parkway
- Suite 800 East
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Flagship Pioneering Investments & Acquisitions (337)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Syros Pharmaceuticals | 05-Jul-2022 | PIPE | 00000 | Drug Discovery | Generating Revenue/Not Profitable | |
000000 | 01-Jun-2022 | 00 000000000 | Electronics (B2C) | Generating Revenue | ||
00000000 000000000 | 26-May-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
000000 00000000000 | 18-May-2022 | 000000 00 00 | Drug Discovery | Generating Revenue | 0000000 0000 00 | |
00000000 000000000 | 01-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Startup | 000000 000000 00.0 |
0000000 | 25-Feb-2022 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
00000000 000000000 | 18-Nov-2021 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | 00000000 000 00000000 00.0 |
0000 | 15-Nov-2021 | 0000 | 00000 | Drug Discovery | Generating Revenue | 0000 000000 |
Alltrna | 09-Nov-2021 | Early Stage VC | 0000 | Drug Discovery | Startup | 000000 00000000 00.0 |
YourBio Health | 02-Sep-2021 | Later Stage VC | 0000 | Other Devices and Supplies | Generating Revenue | 000000 000000 00.0 |
Flagship Pioneering Exits (155)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Axcella | 16-Mar-2022 | Public Investment 2nd Offering | 0000 |
0000000 | 11-Aug-2021 | 000000000000000000 | 00000 |
00000 000000000000 | 30-Jul-2021 | 000 | 00000 |
000000 000000 0000 | 27-Jul-2021 | 000000000000000000 | 0000 |
00000 | 01-Jun-2021 | 000000000 00000000 | |
0000000 0000000 | 01-Jun-2021 | 000000000 00000000 | |
00000 00000000000 | 28-Apr-2021 | 000 00 00000000 | |
0000000 | 10-Mar-2021 | 000000000000000000 | 000.00 |
Codiak | 12-Feb-2021 | Public Investment 2nd Offering | 000.00 |
Sana Biotechnology | 04-Feb-2021 | IPO | 00000 |
Flagship Pioneering Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Flagship Pioneering Investments by Industry, Year, and Region
Flagship Pioneering Team (139)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Michael Severino MD | Chief Executive Officer-Partner | Cambridge, MA | |||
Noubar Afeyan Ph.D | Co-Founder & Chief Executive Officer | 00 | 0 | 00 | Cambridge, MA |
Margaret Georgiadis | Chief Executive Officer - Partner | 00 | 0 | 0 | Cambridge, MA |
Chuck Carelli | Chief Financial Officer | Cambridge, MA | |||
Jeffery Moore | Chief Financial Officer, Flagship Labs | Cambridge, MA |
Flagship Pioneering Co-Investors (115)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
The Invus Group | 7 | 0 |
![]() |
![]() |
|
ARCH Venture Partners | 0 | 0 | 0 |
![]() |
![]() |
Alaska Permanent Fund | 0 | 0 |
![]() |
![]() |
|
Longevity Vision Fund | 0 | 0 |
![]() |
![]() |
|
T. Rowe Price | 0 | 0 |
![]() |
![]() |